chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Strong metallic taste in mouth; Some taste altered; Watery mouth; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6201), via an unspecified route of administration in the left arm on 21Mar2021 at 15:45 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included montelukast (MANUFACTURER UNKNOWN), fluticasone propionate; salmeterol xinafoate (ADVAIR), aspirin (MANUFACTURER UNKNOWN), vitamin (MANUFACTURER UNKNOWN) and doxycycline (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Em9810), via an unspecified route of administration in the left arm on 21Feb2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 14:00, the patient experienced strong metallic taste in mouth, watery mouth and some taste altered. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events strong metallic taste in mouth, watery mouth and some taste altered. The clinical outcomes of the events strong metallic taste in mouth, watery mouth and some taste altered were not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
KINRIX- LOT # 2KL4K- EXPIRED 11/9/23.  PT DID NOT DISPLAY ANY SIGNS OR SYMPTOMS OF DISTRESS AFTER RECEIVING THE VACCINATION.  PT WAS RE-VACCINATED WITH KINRIX PER GUIDELINES DURING SAME OFFICE VISIT.
Patient came in to receive a 2nd dose in their vaccine series. Records show that they had received Moderna on 03/07/2021 and 04/05/2021 with  a Public clinic.
a couple hours after getting the vaccine, patient had arm pain and could not move arm without pain. patient told her husband she thought she was injured. patient says is hurts in the joint, not in the muscle. patient says the bandaid was up higher than in past years. pain persisted for a full day at a high pain level and then decreased in pain for about 2 weeks. Then the pain start coming back in the same place on November 1st 2020. patient said it never completely went away but then noticed it getting worse on 11-1-20. Patient went to her MD on 11-2-20. per patient, at MD visit, MD said patient should rest for 3 days and not go to work for the rest of the week. MD told patient to use OTC anti-imflammatories and rest and to get back to MD on Monday 11-9-20 to decide if should get physical therapy.
1 of 3 pts who exp inject site react which included redness, hot to the touch, tenderness & swelling w/in 48 hrs p/immun; all pts immunized from the same lot & recovered w/no residual sequelae; one of the 4 pts treated w/ATB;
redness, swelling from shoulder to elbow of rt arm;edema, blotchy rash;
sore arm; a little tired; a little headache; a little nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), FATIGUE (a little tired), HEADACHE (a little headache) and NAUSEA (a little nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Peripheral neuropathy (for the past 10 years).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), FATIGUE (a little tired), HEADACHE (a little headache) and NAUSEA (a little nausea). At the time of the report, PAIN IN EXTREMITY (sore arm), FATIGUE (a little tired), HEADACHE (a little headache) and NAUSEA (a little nausea) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant products were not provided. Treatment products were not provided.   This case was linked to MOD-2021-225645 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Event outcomes were updated.
patient reports the area around the injection site became red, swollen and tender. The skin also is extremely itchy, potentially like an allergic reaction
Left arm pain and redness. Edema.  Diagnosed with injection site hematoma.
9:40 AM Blanchy erythema both legs. Warm to touch. 9:50 AM Benadryl 1/2 tsp given per MD. 10:06 erythema resolved, may repeat in 6 hours.
Skin numbness sensation in right side of my back, migrating across top of back at shoulder level.      Extreme sensation of bugs crawling on skin in those areas.   Tingling and numbness down left arm.  Tingling and numbness in thumb and first 2 fingers of left and right hands.  Very high sensitivity to touch on those digits causing sharp pain in fingers with     slight touch pressure or surface contact.  Tingling and numbness on skin surface of right and left thigh and calf.   Slight tingling and numbness in middle toe of right foot. Symptoms subsided gradually over many months.
Hospitalized for weakness, covid positive on 4/2 after being exposed to daughter. Headache, fever, dyspnea, chest pain, nausea, vomiting, diarrhea.
430 or 5AM pt whining; mom gave pt APAP about 4 hrs later p/pt had episodes of slumping; temp checked ax was 104.3; 20 mins later pt started jerking all over-stopped for about 10 mins then started shaking like having a chill; called ER;
Information has been received from a nurse practitioner student concerning a 12 year old female with allergy to ROCEPHIN and no past medical history who on 02-APR-2009 was vaccinated with the first dose of GARDASIL (lot# 659180/1758U). The patient received her second dose of GARDASIL on 23-JUN-2009. There was no concomitant medication. It was reported that after second vaccination, the patient developed a rash over her face and itching over her body. The patient was treated with BENADRYL and ZYRTEC. The patient sought medical attention as the nurse spoke to patient's mother. Additional information has been requested.
Pt recvd vax 21MAR93 & 15JAN94 pt was adm to hosp; lav eval revealed cloudy CSF w/4500 WBC's, 96 polys, 1350 RBC's, protein 159 & glucose 43; BC was pos for haemophilus influenza type A:
12 hours after the injection my son had a tempature of 102 and we could not get it down. He was very miserable and fussy and would not eat or sleep. We are on day 3 and the dr does not seem to be concerned.
about 29 hours after the vaccine, I began to develop a cough/sore throat.  In addition to that, my stomach began to experience pain and feel constipated (started to develop this feeling 42 hours after vaccine).  Have had slight nausea as well. Have tried taking a couple Tylenol which seemed to help.  Currently only symptoms that are persisting are the discomfort in the stomach.
on 11/30/2020 around 2:00pm, I started having chills and a headache. At 3 am, on 12/01/2020, my breathing was not good. I took my inhaler to assist with my breathing. Stayed in bed all day, felt like the flu. Aching and chills still. On 12/02/2020, arm was sore at the site, still had a headache as well.  12/03/2020 I had a sore arm still, but felt better. Doctor I saw virtually told me to take Claritin for 7 days, and I did that.
This spontaneous report was received via a voicemail from a male consumer of unknown age referring to himself. Medical history and concomitant medications were not reported. On an unspecified date the consumer was administered a vaccination with PNEUMOVAX 23 for prophylaxis (dose, route of administration, anatomical location, lot# and expiration date were not reported) and experienced "fever, diarrhea and back pain" on unspecified dates. It is unknown if the patient received treatment for the events. The outcome the events was unknown. The reporter considered the events to be related to PNEUMOVAX 23. No further information was provided by the consumer on the voicemail. Additional information has been requested.
This is in follow-up to report(s) previously submitted on 7/16/2007. Initial and follow up information has been received from a physician concerning a 12 year old female patient who on 22-JUN-2007, at 11:35 AM was vaccinated IM in left arm deltoid with a second dose of GARDASIL lot #655849/0263U. On 22-JUN-2007 the patient experienced "syncope within one minute of vaccination." Unspecified medical attention was sought by the patient. The patient recovered immediately. Additional information is not expected.
Local reaction at injection site redness and swelling, low grade fever nausea aches following HD fluzone lasted 4 to 5 days  ice to injection site OTC pain and fever reducers  fluids
Last summer I noticed that my tinnitus increases in noticeability. I can hear it in my left ear when I talk. This is still going on at this time.
pain in the arm, a tingling, but no big deal; pain in the arm, a tingling, but no big deal; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm, a tingling, but no big deal) and PARAESTHESIA (pain in the arm, a tingling, but no big deal) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced PAIN IN EXTREMITY (pain in the arm, a tingling, but no big deal) and PARAESTHESIA (pain in the arm, a tingling, but no big deal). At the time of the report, PAIN IN EXTREMITY (pain in the arm, a tingling, but no big deal) and PARAESTHESIA (pain in the arm, a tingling, but no big deal) outcome was unknown.            Concomitant medication include High BP medication No treatment information were provided.   This case was linked to MOD-2021-389183, MOD-2021-389210 (Patient Link).
Site: Pain at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Severe, Systemic: Headache-Mild, Additional Details: patient stated she has hives alll over her body , about 5 days after the vaccines. still have rash and itch on 05/24/2021 and will be seeing PCP may 25
Headaches, sore throat, chills, elevated blood pressure, red face, slight cough.
COVID break through case  I received my 1 booster shot on 11/17/2021 and my COVID symptoms started on 05/17/2022 i started with a runny nose, headache, sore throat , fatigue , body ache,  low  grade fever and cough. I tested  05/19/ 2022 a home test which was positive. I  did   a tele health with my doctor she prescribed me  Molnutiravir for 5 days.   I still have  a little bit of all the symptoms except fever but am recovering from COVID.
10 days later pt called to say arm still hurts, swollen and hard to the touch, has worsened since receiving vaccine
It presented as little blisters that itch; Breaking out in different places after receiving the 1st dose; Arm soreness on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (It presented as little blisters that itch), RASH (Breaking out in different places after receiving the 1st dose) and VACCINATION SITE PAIN (Arm soreness on her left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017b21a) for COVID-19 vaccination.     Patient has no medical history.  Concurrent medical conditions included Depression. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for Depression.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced RASH (Breaking out in different places after receiving the 1st dose) and VACCINATION SITE PAIN (Arm soreness on her left arm). On an unknown date, the patient experienced URTICARIA (It presented as little blisters that itch). The patient was treated with MOMETASONE FUROATE for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (It presented as little blisters that itch) and RASH (Breaking out in different places after receiving the 1st dose) had not resolved and VACCINATION SITE PAIN (Arm soreness on her left arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient went to the dermatologist and he mentioned the reaction was due to the vaccine.She was given Mometasone Furoate cream by the dermatologist but it did not work for her. She mentioned that she did not change any soaps or detergents recently.   This case was linked to MOD-2021-384243, MOD-2021-384247 (Patient Link).
states that p/vax had bruised area, swollen to base of neck, had huge knot & base of neck in a direct line from inj site;pt called stated swelling & soreness mostly gone;had some diff raising arm;
Open nasal passage, more than usual; Drying out the back of "my" throat; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 11Aug2021 at 17:00 (at the age of 53-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 12Aug2021 at 16:00, the patient experienced open nasal passage, more than usual and that was drying out the back of throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events open nasal passage, more than usual and that was drying out the back of throat was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Covid arm reaction: exactly 7 days after administration of Dose 1. Swollen arm approximately 5 inches circumference, returning pain at injection site, intense itching  requiring application of Hydrocortisone 1% CREAM.  All symptoms of a "delayed type reaction"  disappeared the following  day except mild pain at injection site.
Administered < 1/2  dose L arm, postulated to be a  syringe and needle assembly failure.  Redosed R arm with full dose.
pt recvd vax 19JAN93, t99.2 @ time of immun; following immun pt exp a fine macular papular rash to both anterior thighs which began approx 36-48 hrs; p/immun & cont 4FEB93; dx contact dermatitis;
After my 1st vaccine I got the site reaction of large, red, itchy on day 8. After my second vaccine in may I began having bladder spasms, possible uti  symptoms and now kidney damage (calleictasis)  that was not present on my CT scan in December of 2020.  I have had an ultrasound, cystoscopy and MRI over the last month trying to figure out what is wrong. They now want to do a surgery... I neverhad this issue before my 2nd dose of Moderna and now I believe this is from my vaccine as it started right after the 2nd dose. I have also never had abnormal kidney labs or calcium. Also my Synthroid dose had to be lowered for the first time in 6 years. I hope that this is not permanent related to my kidney and bladder.
Seven days after administration, my axillary area began to hurt.  Moving was painful, I noticed swelling.  I thought it was swelled lymph nodes.  Soon it was painful to raise my arm, to lie on that side of my body, to have my arm touched.  It was painful to perform activities of daily living (dry hair, wash hair, shave armpits/legs, apply deoderant).  I noticed around day 10 that there seemed to be a hard vessel or tendon that was apparent, and the pain extended to my elbow.  It became difficult to dress, due to the movements required.  I would wake in the night if I laid on the affected arm.  I asked a few physicians I worked with, one said it looked like tendon inflammation, the other said a blood clot.  I went to a local MD who performed ultrasound on my arm and said it looked like the tendon was calcified/inflamed and there was lots of local inflammation.  I was given Vioxx to take to see if  the area would improve. Vaccination date is approximate, I cant find my card at this moment.  It was sometime during the week of Jan 20,2004 on either Tues, Wed, or Thurs, because I went after I started my menstrual period to be sure I wasnt pregnant.  I also took a pregnancy test prior to going.
rash, swollen injection site and swelling down to elbow, pain in arm, headache, all resolved by day 4.
Patient received an expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix) (batch number DK23D, expiry date 8th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (received 1st dose on an unknown date).   On 10th February 2022, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 10th February 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The patient received an expired dose of Twinrix, which led to expired vaccine used.  Healthcare professional did not provide demographics from the patient because did not know if that was possible. The reporter consented to follow up.
Administered SARS-COV-2 (COVID) 2023-24 (6MO-11YR)(MODERNA), MRNA, 0.25 ML DOSE. The patient may have received 0.5mL instead of 0.25mL per dose. The manufacture provided 0.5mL per single dose vial.
Heart Palpitations, Heightened anxiety , Sleeplessness for almost 12hours  Heart Racing. Heavy beating.  Chills, Fever,  Lethargy.
High Fever  102.5 Coughing Complained of Difficulty Breathing Headache Body aches & pains Runny Nose
red line in her arm; raised; hot; scattered bumps; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red line in her arm), VACCINATION SITE SWELLING (raised), VACCINATION SITE WARMTH (hot) and VACCINATION SITE MASS (scattered bumps) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis and Fibromyalgia. Concomitant products included ATORVASTATIN for Cholesterol, DULOXETINE for Fibromyalgia, LEVOTHYROXINE for Hypothyroidism, ETODOLAC for Osteoarthritis, CALCIUM CARBONATE (OSCAL [CALCIUM CARBONATE]) for Supplementation therapy, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red line in her arm), VACCINATION SITE SWELLING (raised), VACCINATION SITE WARMTH (hot) and VACCINATION SITE MASS (scattered bumps). At the time of the report, VACCINATION SITE ERYTHEMA (red line in her arm), VACCINATION SITE SWELLING (raised), VACCINATION SITE WARMTH (hot) and VACCINATION SITE MASS (scattered bumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
they got allergic reactions (after he got the 2nd dose 9 days later and he ended up in the hospital 3 times felt like his throat was swollen and went to the ER they put some injection for allergie; This is a spontaneous report received from a non-contactable consumer. This consumer reported for a 41-year-old male patient . A 41 year old male patient had received bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on unspecified date as DOSE 2, SINGLE for covid-19 immunization.The patient medical history and concomitant medications were not reported . The patient previously took received bnt162b2 (Pfizer-biontech covid-19 vaccine, Solution for injection, Batch/lot number: unknown) via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date the patient had experienced allergic reactions (after he got the 2nd dose 9 days later and he ended up in the hospital 3 times felt like his throat was swollen and went to the ER they put some injection for allergies. The clinical outcome of the event was recovering/resolving.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.